Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fabian

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Cancer Immunology Research|December 23, 2020
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, EnableKellsye P Fabian, Anthony S Malamas, Michelle R Padget, et al.
Plant Biology (Stuttgart, Germany)|March 16, 2007
Synopsis of the CASIROZ case study: carbon sink strength of Fagus sylvatica L. in a changing environment--experimental risk assessment of mitigation by chronic ozone impactR Matyssek, G Bahnweg, R Ceulemans, et al.
The Journal of Pathology|September 15, 2005
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistryR Nenutil, J Smardova, S Pavlova, et al.
Cancer Research Communications|June 29, 2022
Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem CellsAustin T K Hoke, Michelle R Padget, Kellsye P Fabian, et al.
Oncology Reports|April 11, 2009
Significant overexpression of Hsp110 gene during colorectal cancer progressionO Slaby, K Sobkova, M Svoboda, et al.
Journal for Immunotherapy of Cancer|December 23, 2022
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignanciesJoshua T Kowalczyk, Kellsye P Fabian, Michelle R Padget, et al.
Journal for Immunotherapy of Cancer|April 30, 2020
Overcoming hypoxia-induced functional suppression of NK cellsKristen Solocinski, Michelle R Padget, Kellsye P Fabian, et al.
Plant Biology (Stuttgart, Germany)|March 16, 2007
Free-air exposure systems to scale up ozone research to mature treesD F Karnosky, H Werner, T Holopainen, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populationsKellsye P Fabian, Michelle R Padget, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor modelsFrancesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Cancer Immunology Research|December 23, 2020
Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune-Tumor Interactions: Engage, Expand, EnableKellsye P Fabian, Anthony S Malamas, Michelle R Padget, et al.
Plant Biology (Stuttgart, Germany)|March 16, 2007
Synopsis of the CASIROZ case study: carbon sink strength of Fagus sylvatica L. in a changing environment--experimental risk assessment of mitigation by chronic ozone impactR Matyssek, G Bahnweg, R Ceulemans, et al.
The Journal of Pathology|September 15, 2005
Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistryR Nenutil, J Smardova, S Pavlova, et al.
Cancer Research Communications|June 29, 2022
Combinatorial Natural Killer Cell-based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem CellsAustin T K Hoke, Michelle R Padget, Kellsye P Fabian, et al.
Oncology Reports|April 11, 2009
Significant overexpression of Hsp110 gene during colorectal cancer progressionO Slaby, K Sobkova, M Svoboda, et al.
Journal for Immunotherapy of Cancer|December 23, 2022
Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignanciesJoshua T Kowalczyk, Kellsye P Fabian, Michelle R Padget, et al.
Journal for Immunotherapy of Cancer|April 30, 2020
Overcoming hypoxia-induced functional suppression of NK cellsKristen Solocinski, Michelle R Padget, Kellsye P Fabian, et al.
Plant Biology (Stuttgart, Germany)|March 16, 2007
Free-air exposure systems to scale up ozone research to mature treesD F Karnosky, H Werner, T Holopainen, et al.
Journal for Immunotherapy of Cancer|May 23, 2020
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populationsKellsye P Fabian, Michelle R Padget, Renee N Donahue, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor modelsFrancesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Pageof 10